Dana-Farber shared on X:
“Dr. Ravi Uppaluri explores how surgical strategies may evolve following neoadjuvant immunotherapy, examining what these advances could mean for surgical decision-making and patient care.”
You can also read :
25 Posts Not to Miss from ESMO Congress 2026: Day 4
